早期扩髓髓内钉固定治疗合并胸部损伤的股骨干骨折

目的探讨合并胸部损伤的股骨干骨折早期扩髓及髓内钉固定是否增加并发症及死亡率. 方法采用回顾性对比分析,依据下列标准选择病例(1) 年龄在17～65岁;(2) 必须有胸部损伤[简明损伤定级(AIS)≥2], 且损伤严重度评分(ISS)≥16;(3) 住院时间≥48 h;(4) 病史中无明显影响全身状况的疾病, 如糖尿病, 慢性心、肺、肾功能不全等;(5) 有股骨干骨折, 且进行了扩髓髓内钉固定, 不含钢板、外固定支架或牵引及石膏固定者.并按受伤至手术时间划分为两组, A组为<24 h手术者(早期扩髓组), B组为≥24 h手术者(延期扩髓组),将两组间合并伤情况、ISS、住院时间、ICU时间、并发症、死亡及合并休克情况进行比较. 结果有96例符合上述标准, 其中A组57例, B组39例,经统计学处理, 两组间仅在股骨开放性骨折发生率(A组53%,B组31%,χ2=4.496, P<0.05)、合并休克率(A组51%, B组28%,χ2=4.895, P<0.05 )及住院时间[A组为(17.5±6.5)d, B组为(31.5±9.5)d,t=8.599, P<0.001]上差异有显著性意义和非常显著性意义, 而两组并发症发生率和死亡率等方面比较, 差异无显著性意义(P>0.05). 结论在合并胸部损伤的股骨干骨折中,只要能控制休克,保证生命体征平稳,对股骨干骨折行早期扩髓髓内钉固定不增加患者的并发症发生率及死亡率,并可促进患者早日康复,缩短住院时间.     

多系统萎缩的临床分型和影像学改变特点分析

目的探讨多系统萎缩（multiple system atrophy，MSA）的临床表现类型与神经影像学改变新特征（脑桥“十字征”和“壳核裂隙征”）的关系，为临床尽早做出诊断提供依据。方法按照Gilman诊断标准回顾性分析11例MSA患者的临床表现、分型和头颅MRI资料。结果本组诊断为很可能MSA11例，其中橄榄体脑桥小脑萎缩（MSA-C型）8例。2例在发病后3年头颅MRI脑桥“十字征”达Ⅰ期；1例在病后2年达Ⅱ期；3例分别在病后1年、3年、5年达Ⅲ期；另外2例分别在病后2年和7年达Ⅳ期。8例“壳核裂隙征”均为0期。黑质纹状体变性（MSA-P型）2例：1例病后6年脑桥“十字征”0期，“壳核裂隙征”Ⅰ期，另1例发病后9年“壳核裂隙征”Ⅱ期，脑桥“十字征”Ⅳ期。Shy-Drager综合征（MSA-A型）1例：病程5年，MRI检查脑桥“十字征”和“壳核裂隙征”分期均为0期。结论临床表现与头颅MRI检查发现的脑桥“十字征”和“壳核裂隙征”可作为及早识别MSA-C型的神经影像学改变特征，“壳核裂隙征”可作为识别MSA-P型的神经影像学改变特征。     

结节性硬化症的磁共振影像学表现

目的　分析结节性硬化症TSC的MRI表现。方法　 13例经临床证实的TSC病例 ,分析其头部MRI特征性改变。结果　MRI主要征象包括 :①室管膜下结节 :13例均发现病灶 ,T1WI发现 71个 ,T2 WI 39个 ,PDWI 5 6个 ;②皮层及皮层下结节 :11例有阳性发现 ,T2 WI和PDWI各发现 114个病灶 ,T1WI 72个 ;③脑白质异常信号 :5例发现白质病变 ,T2 WI和PDWI各发现 10个病灶 ,T1WI无明确显示 ;④室管膜下巨细胞星形细胞瘤 :仅 1例发现。结论　MRI对TSC的中枢神经系统改变敏感 ,是诊断此病的首选影像学检查方法 ,其中T1WI观察室管膜下结节敏感 ,T2 WI和PDWI观察皮层下及白质病变敏感     

多脏器功能不全综合征患者并发肠源性感染的胃肠功能保护

目的 探讨多脏器功能不全综合征(MODS)患者肠源性感染时胃肠功能管理及预后。方法对32例MODS中伴胃肠衰竭的13例患者的临床资料进行分析。结果 32例MODS患者中，伴发胃肠功能衰竭者13例，ll例成活，2例死亡，死亡率15、4％。结论 重视胃肠功能管理，加强胃肠功能保护是提高MODS患者救治率的重要因素。     

尿动力学检查对膀胱颈硬化症逼尿肌功能评价的研究

目的：探讨如何准确评价膀胱颈硬化症逼尿肌功能。方法：对78例膀胱颈硬化症患者进行了尿动力学检查。结果：单纯性逼尿肌收缩力增高者39例，术后疗效不佳的发生率为0；逼尿肌不稳定者31例，术后疗效不佳的发生率为46%；逼尿肌收缩无力者8例，术后疗效不佳的发生率为100%。结论：应用尿动力学检查来评价膀胱颈硬化症逼尿肌功能，对合理选择病倒，指导临床治疗，提高疗效有重要的价值。     

颅内多发动脉瘤18例临床分析

目的 探讨颅内多发动脉瘤的临床特点及诊治要点。方法 采用回顾性分析对18例共39个颅内多发动脉瘤临床资料进行分析。结果 女性13例，男5例，以1cm左右直径多见，全部经开颅手术治疗，疗效优良率83％(15／18)。结论 ①本组颅内多发动脉瘤多发于女性；②中等大小动脉瘤较常见，主要发生在前循环；③手术治疗效果较理想；④微型动脉瘤极易漏诊；⑤手术应先处理出血侧或易出血侧动脉瘤，并注意手术技巧及要点。     

Fertility in patients with multiple sclerosis: current knowledge and future perspectives

Abstract The issue of fertility in patients with multiple sclerosis (MS) has not been exhaustively studied. Epidemiological data have suggested that spontaneous fecundity might be reduced; several endocrine and sexual disturbances potentially interfering with reproduction have been evidenced in MS patients of both sexes. Moreover, some medical treatments used in MS (e. g., mitoxantrone, cyclophosphamide) may exert detrimental effects on spermatozoa as well as on oocytes, leading to early impairment of fertility. This review illustrates the factors potentially interfering with fertility in MS and discusses the therapeutic tools that may be used to promote fertility in these patients. The safety of hormonal therapies in MS is also examined. The current applications of assisted reproductive technology (ART) are discussed, including in vitro fertilisation (IVF) techniques. Currently available methods to preserve fertility in patients that undergo cytotoxic treatments by means of sperm/oocyte cryostorage or by ovarian fragment cryopreservation and autografting are considered.     

Correction by oral adsorbent of abnormal digestive tract milieu in rats with chronic renal failure

In order to examine the mechanism by which the oral carbonaceousadsorbent, AST-120 delays the appearance of glomerular sclerosis,experiments were carried out in 120 male Sprague-Dawley ratsweighing 285–320 g. The rats were first subjected to 2/3,3/4, and 4/5 nephrectomy (n=40). The experiments were begunat 2 weeks after the surgery, and were performed over an 8-weekperiod. Half of each group (n=20) was administered 1 g/day ofliquid AST-120, and the other half received liquid vehicle solutionwith pair feeding in each group. In the 2/3 nephrectomized groupthe administration of AST-120 delayed the occurrence of glomerularhypertrophy and prevented the appearance of glomerular sclerosiswithout any significant differences in renal function, systemicblood pressure (SBP), and urinary protein excretion (U-P). Inthe 3/4 nephrectomized group the administration of AST-120 delayedthe appearance of glomerular hypertrophy and sclerosis withsignificant decreases in SBP and U-P. In the 4/5 nephrectomizedgroup the administration of AST-120 delayed the appearance ofglomerular sclerosis and prevented a decrease in renal function.It is concluded that administration of the oral adsorbent AST-120delays the occurrence of glomerular sclerosis by delaying theappearance of glomerular hypertrophy, systemic hypertension,and the increase in proteinuria. It can be therefore mentionedthat the accumulating substances in the digestive tract worsenthe abnormal milieu of chronic renal failure.     

IgG指数和IgG合成率在多发性硬化中的应用价值探讨

采用临床流行病学方法对ＩｇＧ指数和ＩｇＧ合成率的实用价值进行评价。结果发现：在对多发性硬化（ＭＳ）的诊断中，ＩｇＧ指数的敏感性、特异性和阳性结果似然比分别是６０％、６５％和１．８０，而ＩｇＧ合成率分别为５０％，６５％和１．４３。在排除皮质类固醇激素的影响后，ＩｇＧ指数的敏感性和阳性结果似然比分别是８４％和２．４，ＩｇＧ合成率则分别是７９％和２．２６。此外，ＩｇＧ指数和ＩｇＧ合成率对于判断是否存在中枢神经系统器质性损害有较大的意义     

A cross-reactive idiotype in scleroderma

Autoantibodies to centromere proteins (anti-CENPs) and to topoisomerase-I are highly specific for scleroderma. Unlike most autoantibodies in other diseases, these autoantibodies are mutually exclusive. We have analysed the idiotypes (Ids) expressed by anti-CENP-B, antitopoisomerase-I, and IgGs from 20 scleroderma patients. Rabbit anti-Ids were prepared to antitopoisomerase-I from two scleroderma patients, and to anti-CENP-B from four patients. These six anti-Ids were used to study the purified autoantibodies from 20 scleroderma patients: four antitopoisomerase-I, 10 anti-CENP-B, and six purified IgG from scleroderma patients who were negative for both autoantibodies. In addition, we studied sera from 40 normal autoantibody-negative controls, and sera and purified immunoglobulins from 17 systemic lupus erythematosus (SLE) patients containing high titres of anti-double-stranded DNA, and/or autoantibodies to extractable nuclear antigens (ENA). Using direct binding, and competitive inhibition ELISAs and immunoblots, we identified an Id present in the heavy chains of all the affinity-purified antitopoisomerase-I, and anti-CENP-B. Interestingly, this Id was also present in the immunoglobulins of the scleroderma patients who had neither of the two autoantibodies. By contrast, cross-reactive Id-EM was not found in the sera or immunoglobulins from 17 SLE patients, or in the sera from 40 normal subjects. Several samples from two patients showed that this cross-reactive Id-EM was stable over time. The scleroderma disease-specific autoantibodies may be identified through a common structural feature at the variable region of the heavy chain: cross-reactive Id-EM.